Ofloxa-Vision Sine (Ofloxacin)

Ofloxacin, the active ingredient in Ofloxa-Vision Sine, is a fluoroquinolone presented as an oral tablet for systemic use. It treats a range of bacterial infections in adult patients when prescribed by a qualified healthcare professional, targeting susceptible Gram‑negative and Gram‑positive organisms under medical supervision.

GNH USA supplies Ofloxa-Vision Sine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU quality standards and is manufactured under GMP conditions. Our global distribution network ensures timely delivery and regulatory compliance across multiple regions.

Ofloxacin is a fluoroquinolone antibiotic used to treat bacterial infections in various organ systems.

- Urinary tract infection: eradicates susceptible uropathogens and resolves symptoms such as dysuria and frequency. - Respiratory tract infection: treats acute exacerbations of bronchitis and community‑acquired pneumonia caused by susceptible bacteria. - Skin and soft‑tissue infection: clears infections like cellulitis and wound infections due to Gram‑negative organisms. - Sexually transmitted infection (gonorrhea): eliminates Neisseria gonorrhoeae strains sensitive to ofloxacin.

Ofloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness - Photosensitivity - Abdominal pain

Serious or Rare Side Effects: - Tendon rupture or tendinitis - QT interval prolongation - Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome) - Clostridioides difficile‑associated diarrhea - Peripheral neuropathy - Hepatotoxicity

When prescribing Ofloxa‑Vision Sine, clinicians should observe several safety precautions to minimize risks. - Indication restriction: use only for infections confirmed or strongly suspected to be caused by susceptible bacteria. - Pregnancy and lactation: avoid use during pregnancy and breastfeeding unless benefits outweigh risks. - Age limitation: not recommended for children under 18 years for most indications. - Renal impairment: adjust dose or monitor renal function in patients with reduced kidney function. - Concomitant medications: avoid simultaneous use with systemic corticosteroids or NSAIDs due to increased tendon injury risk. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture and light.

Ofloxacin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce absorption. - Warfarin: may enhance anticoagulant effect and increase INR. - Theophylline: plasma levels can rise, risking toxicity. - Cyclosporine: increased exposure may lead to nephrotoxicity. - Diabetic agents: risk of hypoglycemia may be heightened.

Moderate Interactions (Monitor Closely): - NSAIDs: combined use raises tendon injury risk. - Corticosteroids: additive risk of tendon rupture. - Antidepressants (e.g., SSRIs): potential QT prolongation. - Antiretrovirals (e.g., zidovudine): may affect drug levels. - Vitamin K antagonists: monitor INR closely.